| Literature DB >> 33614441 |
Hiam R Elnageh1, Murad A Hiblu2, Mohamed Salah Abbassi3, Yousef M Abouzeed1, Mohamed O Ahmed1.
Abstract
Background: Methicillin-resistant staphylococci (MRS) are an emerging global problem with serious public health concern. Aims: This study investigated the prevalence and antimicrobial susceptibility of commensal Staphylococcus species isolated from healthy and clinical cats and dogs.Entities:
Keywords: Coagulase-negative staphylococci; Libya; Staphylococcus; mecA gene; pet animals
Year: 2020 PMID: 33614441 PMCID: PMC7830183 DOI: 10.4314/ovj.v10i4.13
Source DB: PubMed Journal: Open Vet J ISSN: 2218-6050
Proportion and features of staphylococci species isolated from cats and dogs.
| No. of staphylococci | No. of staphylococci by automated system | No. of MRS by automated system | No. of confirmed |
|---|---|---|---|
| Cats (NO = 24)a | CoN=15; | CoN=2 | CoN=2 |
| Dogs (NO = 14)b | CoN=9; | CoN=9 | CoN=1 |
(a) = 1 clinical and 23 healthy; (b) = 4 clinical and 10 healthy; (No.) = Number, (MRS) = methicillin-resistant staphylococci; (CoN) = Coagulase-negative; (CoP) = Coagulase-positive.
Antimicrobial susceptibility profiling and phenotypes of staphylococci as identified by the Phoenix Automated Identification System (n = 38).
| Antibiotic agent | No. and Proportion (%) |
|---|---|
| Gentamicin | 2MRS (5.2%) |
| Imipenem | 13MRS (34.2%) |
| Cefoxitin | 13MRS (34.2%) |
| Cefotaxime | 12MRS (6%) |
| Ampicillin | 33(86.8%) |
| PenicillinG | 33(86.8%) |
| Oxacillin | 13MRS (34.2%) |
| Amoxicillin-Clavulanate | 13MRS (34.2%) |
| Daptomycin | 0(0%) |
| Trimethoprim-Sulfamethoxazole | 1MRS (2.6%) |
| Teicoplanin | 0(0%) |
| Vancomycin | 2(5.2%) |
| Clindamycin | 3(7.8%) |
| Erythromycin | 1MRS-MLSB(2.6%) |
| Fusidic acid | 0 (0%) |
| Linezolid | 0 (0%) |
| Mupirocin | 0 (0%) |
| Nitrofurantoin | 0 (0%) |
| Ciprofloxacin | 1MRS (2.6%) |
| Moxaifloxacin | 0 (0%) |
| Rifampin | 0 (0%) |
| Tetracycline | 0 (90%) |
(MRS) = methicillin-resistant staphylococci; (MLSB) = macrolide-lincosamide-streptogramin B resistance.